Nn9536-4578
Research payments
$1,199,845
Through program year 2024, $1,199,845 in research payments was reported against Nn9536-4578, across 6,972 payments, paid by Novo Nordisk AS.
- Paid by
- Novo Nordisk AS
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $129,785 | 40 |
| 2023 | Research | $196,412 | 273 |
| 2022 | Research | $666,898 | 3,060 |
| 2021 | Research | $206,750 | 3,599 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Jeffrey Geohas Evanston, IL Named on 715 payments
- John Agaiby Kenosha, WI Named on 621 payments
- Kevin Cannon Willmington, NC Named on 471 payments
- George Freeman Poquoson, VA Named on 418 payments
- Neil Fraser Troy, MI Named on 379 payments
- Cynthia Strout North Charleston, SC Named on 302 payments
- Donald Brautigam Westfield, NY Named on 286 payments
- John Porter Montgomery, AL Named on 213 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.